US Broker Ratings

Aurora Cannabis Inc. (ACB) Stock Analysis: Navigating a Potential 18.90% Upside

Aurora Cannabis Inc. (NASDAQ: ACB) is a prominent player in the cannabis industry, headquartered in Edmonton, Canada. Known for its wide range of pharmaceutical-grade cannabis products,..

Nerdy Inc. (NRDY) Stock Analysis: Potential 50% Upside Amid Varied Analyst Ratings

Nerdy Inc. (NRDY), a prominent player in the technology sector operating within the software application industry, presents a compelling case for investors, especially those seeking opportunities..

Quhuo Limited (QH) Stock Analysis: Navigating Challenges with a 52-Week Low

Quhuo Limited (NASDAQ: QH), a Chinese technology company specializing in gig economy services, stands at a pivotal moment for investors seeking to understand its recent performance..

NetClass Technology Inc (NTCL) Stock Analysis: Navigating a Challenging Market with Innovation

NetClass Technology Inc (NASDAQ: NTCL), a burgeoning player in the technology sector, is catching the eye of investors intrigued by its innovative approach to online education...

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a 66.99% Potential Upside

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is drawing attention in the biotechnology sector with a compelling story that could interest investors looking for high-risk, high-reward opportunities. This..

Asure Software Inc (ASUR) Stock Analysis: A 56.92% Potential Upside Awaits Investors

Asure Software Inc (NASDAQ: ASUR) is making waves in the technology sector, particularly in the Software – Application industry, with a compelling potential upside of 56.92%..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Assessing a 25% Potential Upside for Investors

Cytek Biosciences, Inc. (NASDAQ: CTKB), a prominent player in the healthcare sector specializing in medical devices, is garnering attention from investors due to its innovative cell..

Porch Group, Inc. (PRCH) Stock Analysis: Exploring a 7.53% Potential Upside and Strong Analyst Confidence

Porch Group, Inc. (NASDAQ: PRCH) is capturing investor attention with its impressive rise in the technology sector, particularly in the software application industry. With a market..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Unveiling a Potential 177.78% Upside in the Biotech Sector

CytomX Therapeutics, Inc. (NASDAQ: CTMX), a cutting-edge player in the biotechnology industry, presents a compelling investment opportunity within the healthcare sector. Based in South San Francisco,..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Biotech with 86.77% Potential Upside Amid Promising Clinical Trials

Tvardi Therapeutics, Inc. (TVRD), a U.S.-based clinical-stage biopharmaceutical company, has garnered significant attention from investors, thanks to its promising pipeline of therapies targeting fibrosis-driven diseases. With..

SANUWAVE Health, Inc. (SNWV)

⚠️ No article content returned.

..

UroGen Pharma Ltd. (URGN) Stock Analysis: Exploring a 63.77% Potential Upside in the Biotech Sector

For investors with an eye on the healthcare sector, UroGen Pharma Ltd. (NASDAQ: URGN) presents an intriguing opportunity, particularly given its focus on innovative treatments for..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring a 289.75% Potential Upside in Biotech Innovation

aTyr Pharma, Inc. (ATYR), a clinical-stage biotechnology company headquartered in San Diego, California, is making waves in the healthcare sector with its innovative approach to treating..

Aura Biosciences, Inc. (AURA) Stock Analysis: Exploring a Potential 226% Upside in Biotechnology

Aura Biosciences, Inc. (NASDAQ: AURA) is capturing investor attention with its potential for significant stock price appreciation. This clinical-stage biotechnology company, headquartered in Boston, Massachusetts, specializes..

Immutep Limited (IMMP) Stock Analysis: Exploring a 472% Potential Upside in Immunotherapy Innovations

Immutep Limited (NASDAQ: IMMP), an Australia-based biotechnology firm, is capturing the attention of investors with its pioneering work in the immunotherapy landscape. The company stands at..

Neuronetics, Inc. (STIM) Stock Analysis: Unpacking a 93% Potential Upside in the Medical Device Sector

Neuronetics, Inc. (NASDAQ: STIM) has caught the attention of investors with a compelling potential upside of 93.45%, according to analyst ratings. Specializing in innovative treatments for..

Pacific Biosciences of California (PACB) Stock Analysis: Exploring a 58.73% Potential Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a notable player in the healthcare sector under the medical devices industry, presents a compelling case for investors looking..

Chevron Corporation (CVX) Stock Analysis: Balancing Dividend Appeal with Revenue Challenges

Chevron Corporation (NYSE: CVX) remains a staple in the portfolios of many investors, particularly those focused on the energy sector. With a robust market cap of..

XOMA Royalty Corporation (XOMA) Stock Analysis: Exploring Its 92% Potential Upside

XOMA Royalty Corporation (NASDAQ: XOMA), a key player in the biotechnology sector, is capturing investor attention with its significant potential upside. Known for its innovative approach..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a Potential 124.72% Upside

Alpha Teknova, Inc. (NASDAQ: TKNO), a key player in the healthcare sector, specializes in providing critical reagents essential for the discovery, development, and commercialization of innovative..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds